A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of RO 6807952 in Type 2 Diabetic Patients Inadequately Controlled with Metformin Alone.
Phase of Trial: Phase II
Latest Information Update: 13 Jun 2016
At a glance
- Drugs RG 7685 (Primary) ; Liraglutide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Roche
- 10 Jun 2017 Biomarkers information updated
- 13 Feb 2012 Actual patient number (2) added as reported by ClinicalTrials.gov.
- 13 Feb 2012 Planned End Date changed from 1 Dec 2012 to 1 Feb 2012 as reported by ClinicalTrials.gov.